United States

Wright Medical, BioMimetic to combine businesses

Monday, November 19, 2012 02:17 PM

Wright Medical Group, a global orthopedic medical device company, and BioMimetic Therapeutics, a biotech specializing in products to promote the healing of musculoskeletal injuries and diseases, have entered into a definitive agreement for a business combination of the Tennessee-based companies.

More... »

Cmed relocates to larger office in North Carolina

Monday, November 19, 2012 11:41 AM

Cmed, a clinical trials services and advanced software provider, has relocated its North Carolina office to new, larger premises in Creekstone Park, Durham, N.C.. The new 7,700 square foot facility has almost 50% more space than the former office and represents a considerable asset in the drive for the company's growth.

More... »

Factor Bioscience awarded two NIH grants for Alzheimer's research

Monday, November 19, 2012 11:12 AM

The National Institutes of Health, through the National Center for Advancing Translational Sciences, has awarded Factor Bioscience, a developer of cell-based therapeutics and research tools, two Small Business Innovation Research (SBIR) grants to accelerate the development of new treatments for Alzheimer's disease.

More... »

Chimerix appoints Michelle Berrey as CMO

Monday, November 19, 2012 10:45 AM

Chimerix, a Durham, N.C.-based biotechnology company developing orally-available antiviral therapeutics, has appointed Michelle Berrey, MD, MPH, as chief medical officer.

More... »

Saladax Biomedical appoints Myslinski as CCO

Friday, November 16, 2012 12:18 PM

Saladax Biomedical, a Bethlehem, Penn.-based privately held company that develops diagnostic assays for the practical delivery of personalized medicine, has appointed Mark D. Myslinski as senior vice president and chief commercial officer.

More... »

ClinicalRM awarded USAMMDA contract

Friday, November 16, 2012 12:00 PM

Clinical Research Management, a full-service CRO based in Hinckley, Ohio, has been awarded a U.S. Army Medical Materiel Development Activity(USAMMDA) contract. 

More... »

New report shows more than 220 drugs in pipeline for diabetes

Thursday, November 15, 2012 08:00 AM

America's biopharmaceutical research companies currently are developing 221 innovative new medicines to help the nearly 26 million patients in the U.S. affected by diabetes.

More... »

Epic Sciences completes $13M Series B financing to advance cancer diagnostics

Wednesday, November 14, 2012 12:01 PM

Epic Sciences, a La Jolla, Calif.-based private biotech company that develops breakthrough cancer diagnostics, completed a $13 million Series B equity financing. This financing includes new investors Domain Associates, Roche Venture Fund and Pfizer Venture Investments, in addition to undisclosed individual investors.

More... »

Pearl Therapeutics raises $65M Series D to start PT003 phase III trial

Wednesday, November 14, 2012 10:48 AM

Pearl Therapeutics, a Redwood City, Calif.-based privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, has raised a $65 million Series D financing from current investors.

More... »

SNBL USA receives FDA letter declaring all issues resolved

Wednesday, November 14, 2012 10:24 AM

SNBL USA, an Everett, Wash.-based, wholly owned subsidiary of Shin Nippon Biomedical Laboratories, has received a formal close out letter from the FDA indicating that it has successfully resolved all the issues identified in an August 10, 2010, warning letter.

More... »